These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
623 related items for PubMed ID: 6294137
1. Role of apolipoprotein E-containing lipoproteins in abetalipoproteinemia. Blum CB, Deckelbaum RJ, Witte LD, Tall AR, Cornicelli J. J Clin Invest; 1982 Dec; 70(6):1157-69. PubMed ID: 6294137 [Abstract] [Full Text] [Related]
2. Receptor binding activity of high-density lipoproteins containing apoprotein E from abetalipoproteinemic and normal neonate plasma. Innerarity TL, Bersot TP, Arnold KS, Weisgraber KH, Davis PA, Forte TM, Mahley RW. Metabolism; 1984 Feb; 33(2):186-95. PubMed ID: 6319954 [Abstract] [Full Text] [Related]
3. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E. Dergunov AD, Smirnova EA, Merched A, Visvikis S, Siest G, Yakushkin VV, Tsibulsky V. Biochim Biophys Acta; 2000 Feb 24; 1484(1):29-40. PubMed ID: 10685028 [Abstract] [Full Text] [Related]
4. Regulation of low density lipoprotein receptors by plasma lipoproteins from patients with abetalipoproteinemia. Illingworth DR, Alam NA, Sundberg EE, Hagemenas FC, Layman DL. Proc Natl Acad Sci U S A; 1983 Jun 24; 80(11):3475-9. PubMed ID: 6304711 [Abstract] [Full Text] [Related]
5. Regulation of cholesterol synthesis by plasma lipoproteins from patients with abetalipoproteinemia. Alam NA, Illingworth DR, Sundberg EE, Alam SS. Atherosclerosis; 1983 Dec 24; 49(3):295-305. PubMed ID: 6318779 [Abstract] [Full Text] [Related]
6. Plasma lipoprotein composition in alcoholic hepatitis: accumulation of apolipoprotein E-rich high density lipoprotein and preferential reappearance of "light'-HDL during partial recovery. Weidman SW, Ragland JB, Sabesin SM. J Lipid Res; 1982 May 24; 23(4):556-69. PubMed ID: 7097121 [Abstract] [Full Text] [Related]
7. Increases in dietary cholesterol and fat raise levels of apoprotein E-containing lipoproteins in the plasma of man. Cole TG, Patsch W, Kuisk I, Gonen B, Schonfeld G. J Clin Endocrinol Metab; 1983 Jun 24; 56(6):1108-15. PubMed ID: 6841553 [Abstract] [Full Text] [Related]
8. In vivo metabolism of apolipoproteins A-I and E in patients with abetalipoproteinemia: implications for the roles of apolipoproteins B and E in HDL metabolism. Ikewaki K, Rader DJ, Zech LA, Brewer HB. J Lipid Res; 1994 Oct 24; 35(10):1809-19. PubMed ID: 7852858 [Abstract] [Full Text] [Related]
9. Elevated levels of apolipoprotein E in the high density lipoproteins of human cord blood plasma. Blum CB, Davis PA, Forte TM. J Lipid Res; 1985 Jun 24; 26(6):755-60. PubMed ID: 4031653 [Abstract] [Full Text] [Related]
10. Molecular and metabolic basis for the metabolic disorder normotriglyceridemic abetalipoproteinemia. Hardman DA, Pullinger CR, Hamilton RL, Kane JP, Malloy MJ. J Clin Invest; 1991 Nov 24; 88(5):1722-9. PubMed ID: 1939657 [Abstract] [Full Text] [Related]
11. Effect of copper deficiency on the apolipoprotein E-rich high density lipoproteins in rats. Croswell SC, Lei KY. J Nutr; 1985 Apr 24; 115(4):473-82. PubMed ID: 3981266 [Abstract] [Full Text] [Related]
12. Abnormal high density lipoproteins of abetalipoproteinemia: relevance to normal HDL metabolism. Deckelbaum RJ, Eisenberg S, Oschry Y, Cooper M, Blum C. J Lipid Res; 1982 Dec 24; 23(9):1274-82. PubMed ID: 7161557 [Abstract] [Full Text] [Related]
14. Regulation of the apolipoprotein E by dietary lipids occurs by transcriptional and post-transcriptional mechanisms. Srivastava RA. Mol Cell Biochem; 1996 Feb 23; 155(2):153-62. PubMed ID: 8700160 [Abstract] [Full Text] [Related]
15. Individual variation in the effects of dietary cholesterol on plasma lipoproteins and cellular cholesterol homeostasis in man. Studies of low density lipoprotein receptor activity and 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in blood mononuclear cells. Mistry P, Miller NE, Laker M, Hazzard WR, Lewis B. J Clin Invest; 1981 Feb 23; 67(2):493-502. PubMed ID: 6257763 [Abstract] [Full Text] [Related]
18. Low density lipoprotein from humans supplemented with n-3 fatty acids depresses both LDL receptor activity and LDLr mRNA abundance in HepG2 cells. Lindsey S, Pronczuk A, Hayes KC. J Lipid Res; 1992 May 23; 33(5):647-58. PubMed ID: 1535648 [Abstract] [Full Text] [Related]
19. Overexpression of apolipoprotein E in transgenic mice: marked reduction in plasma lipoproteins except high density lipoprotein and resistance against diet-induced hypercholesterolemia. Shimano H, Yamada N, Katsuki M, Shimada M, Gotoda T, Harada K, Murase T, Fukazawa C, Takaku F, Yazaki Y. Proc Natl Acad Sci U S A; 1992 Mar 01; 89(5):1750-4. PubMed ID: 1542669 [Abstract] [Full Text] [Related]
20. Heterogeneity of human high density lipoprotein: presence of lipoproteins with and without apoE and their roles as substrates for lecithin:cholesterol acyltransferase reaction. Marcel YL, Vezina C, Emond D, Suzue G. Proc Natl Acad Sci U S A; 1980 May 01; 77(5):2969-73. PubMed ID: 6930680 [Abstract] [Full Text] [Related] Page: [Next] [New Search]